Fairmount Funds Management LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $459 Million distributed in 17 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Cogent Biosciences, Inc. with a value of $129M, Axsome Therapeutics, Inc. with a value of $99M, Viridian Therapeutics, Inc.\De with a value of $74.4M, Scholar Rock Holding Corp with a value of $68.1M, and Nuvalent, Inc. with a value of $62.9M.
Examining the 13F form we can see an increase of $133M in the current position value, from $326M to 459M.
Fairmount Funds Management LLC is based out at Philadelphia, PA
Below you can find more details about Fairmount Funds Management LLC portfolio as well as his latest detailed transactions.
